Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : UROLOGIX (ULGX)--The next big thing! -- Ignore unavailable to you. Want to Upgrade?

To: Mel Spivak who wrote (42)	2/6/1998 5:55:00 PM
From: Willie Theis	Read Replies (1) \| Respond to of 73

Mel, Thanks for your post. I'm sticking with ULGX because of the demographics and the potential reward. I would really appreciate it very much if you could elaborate with specifics what you meant in your post that IR at ULGX gave no response to you, and what the info was you were looking for from them. Also, do you have that Ph. #. I just spoke with my broker at Dain Bosworth and he still really likes it long term, and I believe Dain has a 12-month target of something like 27 or 28. He also said ULGX is now approved for Medicare reimbursement in 47 states, that is up from just 37 not that long ago. Again, your response would be appreciated. Thank you. Willie